Obesity and diabetes treatment
Perhaps the most visible example is the revolution in obesity and diabetes treatment. GLP-1 therapies are already reducing obesity rates for the first time in decades. Type 2 diabetes, which affects the vast majority of diabetics worldwide, is increasingly treatable at the root. This is not just about weight. It is about avoiding cardiovascular disease, joint replacements, renal failure, and decades of reduced mobility.
For people, the benefits are tangible. Fewer years spent sick. Fewer medications. Fewer hospital visits. More energy. More independence. More time with family. More ability to work, travel, and enjoy life well into older age.